Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the recent release of its Nach01 foundation model on Amazon Web Services (AWS), available via AWS Marketplace, a curated storefront helping companies of all sizes find, buy, and deploy solutions from AWS Partners. The launch represents a major step in the ongoing collaboration between AWS and Insilico Medicine’s Pharma.AI Platform, aimed at providihuanlegeng access to advanced AI tools for drug design. Nach01 leverages a large language model to process both structural and spatial data. Combining strengths from both predecessors, Nach01 is designed to solve hundreds of diverse tasks, providing a broad and comprehensive range of chemical knowledge.